• Retatrutide - NuroCore
1 1

NuroCore

Retatrutide

Retatrutide

699.00 AED
1,676.00 AED 699.00 AED
Sale Sold out
Shipping calculated at checkout.
Size

Retatrutide (LY3437943) is a next-generation triple agonist of GLP-1, GIP, and glucagon receptors. It is studied for its synergistic effects on weight management, glycemic control, and metabolic health. Within NuroCore, Retatrutide is categorized under Metabolic & Weight Management Research.

View full details


Concentration: Commonly10 mg, 20 mg, or 30 mg vials (lyophilized powder)

Composition: Synthetic 39–amino acid tri-agonist peptide

Formulation: Lyophilized acetate buffered polypeptide

Half-Life: Extended; engineered for once-weekly dosing in research

Primary Actions: GLP-1, GIP, GCGR agonism for metabolic studies


Shown to induce significant weight reduction in experimental studies.

Studied for reducing liver fat and improving metabolic markers.

Demonstrates enhanced efficacy vs single or dual incretin agonists.

Explored in obesity and diabetes research programs.


Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until dissolved.

Handle only under sterile laboratory conditions.


Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.


Category: Metabolic & Weight Management Research (NuroCore)

Use Case: Research into obesity, glycemic regulation, and metabolic optimization

Compliance Note: Classified strictly as a research compound

Other customers also bought

View all